Evidence map›Paper›PMID 42889982›Full record

ArticleACS omega2026

Design and Characterization of Bovine Serum Albumin Hydrogels: A Promising Platform for Controlled Drug Delivery.

Eva M M Velez, María C Maldonado Galdeano, Rosana Chehín, Silvina Chaves

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eva M M VelezInstituto de Investigación en Medicina Molecular y Celular Aplicada (IMMCA) (CONICET), Universidad Nacional de Tucumán (UNT), Ministerio de Salud Pública de Tucumán - SIPROSA, Pasaje Dorrego 1080, 4000 San Miguel de Tucumán, Tucumán, Argentina.
María C Maldonado GaldeanoCentro de Referencia para Lactobacilos (CERELA-CONICET), Batalla de Chacabuco 145, T4000ILC San Miguel de Tucumán, Tucumán, Argentina.
Rosana ChehínInstituto de Investigación en Medicina Molecular y Celular Aplicada (IMMCA) (CONICET), Universidad Nacional de Tucumán (UNT), Ministerio de Salud Pública de Tucumán - SIPROSA, Pasaje Dorrego 1080, 4000 San Miguel de Tucumán, Tucumán, Argentina.
Silvina ChavesInstituto de Investigación en Medicina Molecular y Celular Aplicada (IMMCA) (CONICET), Universidad Nacional de Tucumán (UNT), Ministerio de Salud Pública de Tucumán - SIPROSA, Pasaje Dorrego 1080, 4000 San Miguel de Tucumán, Tucumán, Argentina.ORCID https://orcid.org/0000-0003-2003-9386

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-based hydrogels have attracted increasing interest as biocompatible matrices for drug delivery; however, simple systems based exclusively on albumin remain relatively underexplored. Here, we report the formation of bovine serum albumin (BSA) hydrogels generated through mild thermal aggregation (65 °C) without chemical cross-linkers, employing low protein concentrations (1-1.5%). The influence of the buffering environment (PBS vs Tris-HCl) on hydrogel architecture was identified as a key structural determinant. The resulting hydrogels were systematically characterized in terms of their structure, swelling behavior, water content, biodegradability, and morphology. Microscopic analyses revealed that Tris-HCl promoted the formation of a homogeneous and dense amyloid-like fibrillar network, whereas PBS led to more heterogeneous and irregular architectures. These structural differences affected the capacity to absorb and release model compounds with distinct physicochemical properties, producing sustained and matrix-dependent release profiles.

Identifiers

PMID42889982
PMCPMC13670805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.